In this episode, Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center, shares progress in pediatric leukemia and sickle cell disease treatments, the impact of a 30-year partnership with Aflac, and breakthroughs in precision medicine, CAR T-cell therapy, and gene therapy that are reshaping outcomes for children and families.
Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center
Advertisement
Advertisement
Next Up in Becker’s Pediatric Leadership Podcast
-
In this episode, Kimberly Chavalas Cripe, President and CEO of Rady Children’s Health, discusses expanding access to specialized pediatric care,…
-
This episode recorded live at the Becker’s 11th Annual Health IT + Digital Health + RCM Conference features Luis Taveras,…
-
In this episode, Jacob Emerson, Associate News Director, Becker’s Healthcare, joins Scott Becker to discuss rising employer-sponsored insurance costs, potential…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
Advertisement
Comments are closed.